AccuraGen Holdings Limited


About Us

Since its inception in 2013, AccuraGen has pioneered the development of liquid biopsy technology to facilitate more personalized cancer treatment. Our international team of scientists brings together the best of industry with the best of academia. We currently operate from two locations: Menlo Park, California and Shanghai, China.

Management team

Kang Ying

MD/PhD
CEO

co-founder

Shengrong Lin

MD/PhD
CTO

co-founder

Malek Faham

MD/PhD
Interim CSO

Johnny Sun

MS/MS
CIO

co-founder

Li Weng

PhD
VP of Development

Paul Tang

PhD
VP of BD & Product co-founder

Grace Zhao

PhD
Director of Research

co-founder

Advisor

Richard Myers, PhD

The former director of the Stanford Human Genome Center, Dr. Myers currently serves as the president of the HudsonAlpha Institute for Biotechnology.

David Euhus, MD

Dr. David Euhus is the chief of breast surgery in the Department of Surgical Oncology at Johns Hopkins University.

Board

Kang Ying

MD/PhD/Chairman 

Shengrong Lin

MD/PhD/Director

Min Cui

PhD/Director
+ Managing Director of Decheng Capital

Wei Xu

MEC Director
+ Executive Partner of Denlux Capital

Dan Zabrowski

Independent Director
+ Head of Roche Sequencing and Tissue Diagnostics

Kevin Liu

Director
+ General Manager of Junson Capital

Investors